Pharmacogenomic Characterization of a Large Cohort of Patient-Derived Cell Lines Identifies Therapeutic Strategies for Pleural Mesothelioma
Jean‐Baptiste Assié, Clément Meiller, Esther Stern, Julie Lasvergnas et autres
2 citationsCancer Research
Clément Meiller
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
47Publications signalées
2620Citations signalées
5Affiliations récentes
Institutions déclarées
Domaines associés
Occupational and environmental lung diseasesCancer Research and TreatmentsCancer Genomics and DiagnosticsTissue Engineering and Regenerative MedicineMedical Imaging and Pathology Studies
Publications récentes
239MO: Stratification of pleural mesothelioma patients for combined immunotherapy based on sarcomatoid component and tumour microenvironment markers in the IFCT-MAPS2 study
Giovanna Tosato, Yuna Blum, J-B. Assié, Ruth Sequeiros et autres
1 citationJournal of Thoracic Oncology
Data from Combined MEK and PI3K/p110β Inhibition as a Novel Targeted Therapy for Malignant Mesothelioma Displaying Sarcomatoid Features
Miriam Marqués, Robin Tranchant, Blanca Risa-Ebrí, María L. Suárez-Solís et autres
0 citations
Data from Combined MEK and PI3K/p110β Inhibition as a Novel Targeted Therapy for Malignant Mesothelioma Displaying Sarcomatoid Features
Miriam Marqués, Robin Tranchant, Blanca Risa-Ebrí, María L. Suárez-Solís et autres
0 citations
Supplementary Data from Combined MEK and PI3K/p110β Inhibition as a Novel Targeted Therapy for Malignant Mesothelioma Displaying Sarcomatoid Features
Miriam Marqués, Robin Tranchant, Blanca Risa-Ebrí, María L. Suárez-Solís et autres
0 citations
Legends of Supplementary Figures from Co-occurring Mutations of Tumor Suppressor Genes, LATS2 and NF2, in Malignant Pleural Mesothelioma
Robin Tranchant, Lisa Quetel, Anne Tallet, Clément Meiller et autres
0 citations
Supplementary Tables S1-S5 from Co-occurring Mutations of Tumor Suppressor Genes, LATS2 and NF2, in Malignant Pleural Mesothelioma
Robin Tranchant, Lisa Quetel, Anne Tallet, Clément Meiller et autres
0 citations
Supplementary Material and Methods from Co-occurring Mutations of Tumor Suppressor Genes, LATS2 and NF2, in Malignant Pleural Mesothelioma
Robin Tranchant, Lisa Quetel, Anne Tallet, Clément Meiller et autres
0 citations
Supplementary Figures S1-S7 from Co-occurring Mutations of Tumor Suppressor Genes, LATS2 and NF2, in Malignant Pleural Mesothelioma
Robin Tranchant, Lisa Quetel, Anne Tallet, Clément Meiller et autres
0 citations
Supplementary Tables S1-S5 from Co-occurring Mutations of Tumor Suppressor Genes, LATS2 and NF2, in Malignant Pleural Mesothelioma
Robin Tranchant, Lisa Quetel, Anne Tallet, Clément Meiller et autres
0 citations
Legends of Supplementary Figures from Co-occurring Mutations of Tumor Suppressor Genes, LATS2 and NF2, in Malignant Pleural Mesothelioma
Robin Tranchant, Lisa Quetel, Anne Tallet, Clément Meiller et autres
0 citations
Supplementary Material and Methods from Co-occurring Mutations of Tumor Suppressor Genes, LATS2 and NF2, in Malignant Pleural Mesothelioma
Robin Tranchant, Lisa Quetel, Anne Tallet, Clément Meiller et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.